<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:53:24Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:4060432" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:4060432</identifier><datestamp>2014-07-01</datestamp><setSpec>ijendocrin</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Int J Endocrinol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Int J Endocrinol</journal-id>
      <journal-id journal-id-type="publisher-id">IJE</journal-id>
      <journal-title-group>
        <journal-title>International Journal of Endocrinology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1687-8337</issn>
      <issn pub-type="epub">1687-8345</issn>
      <publisher>
        <publisher-name>Hindawi Publishing Corporation</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4060432</article-id>
      <article-id pub-id-type="pmcid">PMC4060432</article-id>
      <article-id pub-id-type="pmc-uid">4060432</article-id>
      <article-id pub-id-type="pmid">24987415</article-id>
      <article-id pub-id-type="doi">10.1155/2014/185974</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Two Novel <italic>CYP11B1</italic> Gene Mutations in Patients from Two Croatian Families with 11<italic><italic>Î²</italic></italic>-Hydroxylase Deficiency</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Dumic</surname>
            <given-names>Katja</given-names>
          </name>
          <xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref>
          <xref ref-type="corresp" rid="cor1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yuen</surname>
            <given-names>Tony</given-names>
          </name>
          <xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Grubic</surname>
            <given-names>Zorana</given-names>
          </name>
          <xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kusec</surname>
            <given-names>Vesna</given-names>
          </name>
          <xref ref-type="aff" rid="I4">
<sup>4</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barisic</surname>
            <given-names>Ingeborg</given-names>
          </name>
          <xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>New</surname>
            <given-names>Maria I.</given-names>
          </name>
          <xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="I1"><sup>1</sup>Division of Clinical Genetics, Department of Pediatrics, Children's University Hospital Zagreb, Klaiceva 16, 10000 Zagreb, Croatia</aff>
      <aff id="I2"><sup>2</sup>Steroid Disorder Program, Department of Pediatrics, Mount Sinai School of Medicine, New York, NY 10029, USA</aff>
      <aff id="I3"><sup>3</sup>Tissue Typing Centre, University Hospital Centre Zagreb, 10000 Zagreb, Croatia</aff>
      <aff id="I4"><sup>4</sup>Department of Laboratory Medicine, University Hospital Centre Zagreb, 10000 Zagreb, Croatia</aff>
      <author-notes>
        <corresp id="cor1">*Katja Dumic: <email>katjadumic1@gmail.com</email></corresp>
        <fn fn-type="other">
          <p>Academic Editor: MaÅgorzata Kotula-Balak</p>
        </fn>
      </author-notes>
      <pub-date pub-type="ppub">
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>2</day>
        <month>6</month>
        <year>2014</year>
      </pub-date>
      <volume>2014</volume>
      <elocation-id>185974</elocation-id>
      <history>
        <date date-type="received">
          <day>9</day>
          <month>2</month>
          <year>2014</year>
        </date>
        <date date-type="rev-recd">
          <day>1</day>
          <month>5</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>5</day>
          <month>5</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright Â© 2014 Katja Dumic et al.</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license xlink:href="https://creativecommons.org/licenses/by/3.0/">
          <license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Steroid 11<italic><italic>Î²</italic></italic>-hydroxylase deficiency (11<italic><italic>Î²</italic></italic>-OHD) is the second most common cause of congenital adrenal hyperplasia. Mutations in the <italic>CYP11B1</italic> gene, which encodes steroid 11<italic><italic>Î²</italic></italic>-hydroxylase, are responsible for this autosomal recessive disorder. Here, we describe the molecular genetics of two previously reported male siblings in whom diagnosis of 11<italic><italic>Î²</italic></italic>-OHD has been established based on their hormonal profiles displaying high levels of 11-deoxycortisol and hyperandrogenism. Both patients are compound heterozygous for a novel p.E67fs (c.199delG) mutation in exon 1 and a p.R448H (c.1343G&gt;A) mutation in exon 8. We also report the biochemical and molecular genetics data of one new 11<italic><italic>Î²</italic></italic>-OHD patient. Sequencing of the <italic>CYP11B1</italic> gene reveals that this patient is compound heterozygous for a novel, previously undescribed p.R141Q (c.422G&gt;A) mutation in exon 3 and a p.T318R (c.953C&gt;G) mutation in exon 5. All three patients are of Croatian (Slavic) origin and there is no self-reported consanguinity in these two families. Results of our investigation confirm that most of the <italic>CYP11B1</italic> mutations are private. In order to elucidate the molecular basis for 11<italic><italic>Î²</italic></italic>-OHD in the Croatian/Slavic population, it is imperative to perform <italic>CYP11B1</italic> genetic analysis in more patients from this region, since so far only four patients from three unrelated Croatian families have been analyzed.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec id="sec1">
      <title>1. Introduction</title>
      <p>
Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders caused by the loss of one of five steroidogenic enzymes involved in cortisol synthesis. Approximately 90â95% of all cases are due to steroid 21-hydroxylase deficiency, and about 3â8% are caused by steroid 11<italic>Î²</italic>-hydroxylase deficiency (11<italic>Î²</italic>-OHD) [<xref rid="B1" ref-type="bibr">1</xref>â<xref rid="B3" ref-type="bibr">3</xref>]. The deficiency of 11<italic>Î²</italic>-OH leads to reduced cortisol biosynthesis, increased ACTH secretion, and overproduction of steroid precursors. These precursors are shunted toward androgen synthesis, resulting in hyperandrogenism. Phenotypical expression of classic 11<italic>Î²</italic>-OHD leads to virilization of external genitalia in newborn females. The overproduction of reactive androgen also causes precocious pseudopuberty, accelerated somatic growth, and premature epiphyseal closure in both sexes. The accumulation of 11-deoxycorticosterone and its metabolites causes hypertension in about two-thirds of these patients.</p>
      <p>The gene for steroid 11<italic>Î²</italic>-hydroxylase is encoded by<italic> CYP11B1</italic>. It is located on chromosome 8q22, approximately 40âkb apart from the highly homologous<italic> CYP11B2</italic> gene that encodes the aldosterone synthase. To date, over 90 disease-causing<italic> CYP11B1</italic> mutations have been identified [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>]. Notably, a high incidence of 11<italic>Î²</italic>-OHD has been reported, with a disease frequency of about 1 in 5,000â7,000 live births, in Israel among Jewish immigrants from Morocco, a relatively inbred population. Almost all alleles in this patient group carry the same p.R448H (c.1343G&gt;A, rs28934586) missense mutation in exon 8 [<xref rid="B6" ref-type="bibr">6</xref>â<xref rid="B8" ref-type="bibr">8</xref>]. Recently, we described one 11<italic>Î²</italic>-OHD patient of the Slavic origin who was compound heterozygous for this p.R448H mutation and a novel intron 7 (c.1200+4A&gt;G) splice site mutation [<xref rid="B9" ref-type="bibr">9</xref>]. It was the first report of<italic> CYP11B1</italic> genetic analysis in a Croatian patient with 11<italic>Î²</italic>-OHD.</p>
      <p>Here, we further report two novel<italic> CYP11B1</italic> mutations from three more patients of the Croatian descent, which include two previously reported brothers [<xref rid="B10" ref-type="bibr">10</xref>] and one new patient.</p>
    </sec>
    <sec id="sec2">
      <title>2. Subjects and Methods</title>
      <sec id="sec2.1">
        <title>2.1. Subjects</title>
        <sec id="sec2.1.1">
          <title>2.1.1. Family A</title>
          <p>Patient 1 is the older of two sons of healthy nonconsanguineous parents of the Croatian descent. He was diagnosed at 2.5 years of age due to accelerated growth, skeletal maturation, pseudoprecocious puberty, elevated serum levels of 11-deoxycortisol, 17-hydroxyprogesterone (17-OHP), and androgens, and suppressed levels of cortisol, aldosterone, and plasma renin activity (PRA). His blood pressure was high normal. Patient 2 is the younger brother of Patient 1. He was diagnosed at 3 months of age, with clinical presentation almost identical to his older brother, except for a normal blood pressure. Hydrocortisone treatments for both patients were introduced immediately after diagnosis.</p>
          <p>Patients 1 and 2, now 30 and 28 years old, respectively, have not been under our pediatric care or taking medication on a regular basis for the past 15 years. They came to us recently for genetic counseling. During this visit, blood was drawn for<italic> CYP11B1</italic> gene analysis.</p>
        </sec>
        <sec id="sec2.1.2">
          <title>2.1.2. Family B</title>
          <p>Patient 3, the first child of healthy nonconsanguineous parents of the Croatian descent, was born spontaneously at term after an uneventful pregnancy. At 2 years of age, he was presented for the first time with growth acceleration and pseudoprecocious puberty. His height was 100âcm (+4.27âSD) and his weight was 19.5âkg (+3.9âSD). He had deep voice, acne, and large phallus (length 7âcm, circumference 4.5âcm). His testes were 2-3âcc, and his pubic hair was Tanner II. Blood pressure was normal (90/45âmmHg). Bone age according to Greulich and Pyle was 5 years. Plasma electrolytes were normal. Biochemical results confirmed diagnosis of 11<italic>Î²</italic>-OHD (<xref ref-type="table" rid="tab1">Table 1</xref>) and hydrocortisone treatment (12âmg/m<sup>2</sup>/day) was subsequently started.</p>
          <p>His younger brother was admitted at 6 months of age. He had no signs of accelerated growth and sexual development, and his plasma levels of 11-deoxycortisol, 17-OHP, androgens, aldosterone, and PRA were within normal range for age, suggesting that he was not affected with CAH.</p>
        </sec>
      </sec>
      <sec id="sec2.2">
        <title>2.2. Hormonal Assays</title>
        <p>Blood for biochemical analyses was drawn after an overnight fast. Serum/plasma was either assayed immediately or frozen for later use. Standard recommended biochemical methods for measured parameters were employed.</p>
      </sec>
      <sec id="sec2.3">
        <title>2.3. DNA Amplification and Sequence Analysis</title>
        <p>Genomic DNA was isolated from peripheral leukocytes. Three DNA fragments (exons 1-2, 3â5, and 6â9) of the<italic> CYP11B1</italic> gene were amplified by polymerase chain reaction (PCR). Reactions were carried out in 50â<italic>Î¼</italic>L volume, which contained 100âng genomic DNA, 10âmM Tris-HCl, pH 8.3, 50âmM potassium chloride, 1.5âmM magnesium chloride, 200â<italic>Î¼</italic>M deoxynucleotide triphosphates, 2.5 units JumpStart<italic> Taq</italic> DNA Polymerase (Sigma, St. Louis, MI, USA), and 200ânM each of<italic> CYP11B1</italic>-specific sense and antisense primers (<xref ref-type="table" rid="tab2">Table 2</xref>). Thermocycling was performed in a Mastercycler (Eppendorf, Hauppauge, NY, USA) with an initial 3-minute denaturation step at 94Â°C followed by 35 cycles of 94Â°C for 45 seconds, 58Â°C for 30 seconds, and 72Â°C for 3 minutes. The expected amplicon sizes were 0.9âkb, 1.4âkb, and 1.5âkb for the exon 1-2, 3â5, and 6â9 fragments, respectively, and were confirmed by agarose gel electrophoresis. After purification with a QIAquick PCR Purification Kit (Qiagen, Valencia, CA, USA), direct sequencing of the amplicons was performed using primers listed in <xref ref-type="table" rid="tab2">Table 2</xref>. The sequencing results were compared to the 7.46âkb human<italic> CYP11B1</italic> reference sequence at chromosome 8 (GenBank gi|224589820:c143961236-143953773).</p>
      </sec>
    </sec>
    <sec id="sec3">
      <title>3. Results</title>
      <p>More than two decades ago, at a time before modern molecular diagnostic tools were available, we described two brothers (Patients 1 and 2) with 11<italic>Î²</italic>-OHD [<xref rid="B9" ref-type="bibr">9</xref>]. These two patients recently visited our clinic for genetic counseling. This gave us an opportunity to perform genetic analysis of their<italic> CYP11B1</italic> gene. DNA sequencing results showed that both patients carried a novel p.E67fs (p.E67Kfsâ9, c.199delG) frameshift mutation in exon 1 and a previously reported p.R448H (c.1343G&gt;A) missense mutation in exon 8 (Figures <xref ref-type="fig" rid="fig1">1</xref> and <xref ref-type="fig" rid="fig3">3</xref>). The p.E67fs mutation causes a reading frame shift, resulting in premature translation termination at codon 75.</p>
      <p>For Patient 3, deficiency of 11<italic>Î²</italic>-OH was suspected on the basis of his clinical presentation. This is confirmed by hormonal analyses, which showed elevated serum levels of 11-deoxycortisol, androstenedione, testosterone, and 17-OHP and suppressed levels of cortisol, aldosterone, and plasma renin activity (<xref ref-type="table" rid="tab1">Table 1</xref>). Genetic analysis of the<italic> CYP11B1</italic> gene revealed that Patient 3 carried a novel, previously undescribed p.R141Q (c.422G&gt;A, rs26701810) missense mutation in exon 3 and a previously reported p.T318R (c.953C&gt;G) missense mutation in exon 5 (Figures <xref ref-type="fig" rid="fig2">2</xref> and <xref ref-type="fig" rid="fig3">3</xref>) [<xref rid="B11" ref-type="bibr">11</xref>].</p>
      <p>In both families, DNA of the parents was not available for genetic analysis. Since all three patients have clear clinical and biochemical characteristics of 11<italic>Î²</italic>-OHD, we assume that the patients are compound heterozygotes, and that the mutations are located on different alleles.</p>
    </sec>
    <sec id="sec4">
      <title>4. Discussion</title>
      <p>Patients 1, 2, and 3 were presented at the age of 2.5 years, 3 months, and 2 years, respectively, with characteristic features for boys with 11<italic>Î²</italic>-OHD. Accelerated somatic growth and skeletal maturation and pseudoprecocious puberty were found in all three patients. Although their blood pressure was normal, their hormonal profile was distinctive of 11<italic>Î²</italic>-OHD, with elevated serum levels of 11-deoxycortisol, 17-OHP, and androgens and suppressed levels of cortisol, aldosterone, and PRA.</p>
      <p>At present, over 90 different<italic> CYP11B1</italic> gene mutations have been described. Whereas the majority of these are missense and nonsense mutations, other mutations have also been reported, which include splice site mutations, small and large deletions/insertions, and complex rearrangements. These mutations are distributed over the entire coding region but tend to cluster in exons 2, 6, 7, and 8 [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>].</p>
      <p>There is no consistent correlation between a specific<italic> CYP11B1</italic> gene mutation and the clinical phenotype of 11<italic>Î²</italic>-OHD. Distinctive phenotypic variability exists in patients with the same mutation regarding the onset of symptoms, the age of diagnosis, the degree of virilization, or the severity of hypertension [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>]. Nonetheless, based on<italic> in vitro</italic> expression data, the p.R448H mutation completely abolished 11<italic>Î²</italic>-hydroxylase enzymatic activity [<xref rid="B12" ref-type="bibr">12</xref>]. The c.199delG frameshift mutation should result in premature translational termination and production of a nonfunctional protein. The compound heterozygous c.199delG/p.R448H mutation therefore predicts a severe classic CAH phenotype in Patients 1 and 2. Similarly, the T318 residue is completely conserved in all known P450 enzymes. Any changes in this position, for example, either a p.T318âM or a p.T318R mutation, causes loss of 11<italic>Î²</italic>-hydroxylase activity [<xref rid="B1" ref-type="bibr">1</xref>]. Although the consequence of the p.R141Q mutation is unknown, based on the severe clinical phenotype observed in Patient 3, we predict that the p.R141Q mutation causes major loss of 11<italic>Î²</italic>-hydroxylase activity. The mutation of a positively charged arginine to an uncharged glutamine residue could break a salt bridge necessary for maintaining conformational stability of the enzyme.<italic> In silico</italic> mutation analyses were performed using PolyPhen-2 (<ext-link ext-link-type="uri" xlink:href="http://genetics.bwh.harvard.edu/pph2/">http://genetics.bwh.harvard.edu/pph2/</ext-link>), SIFT (<ext-link ext-link-type="uri" xlink:href="http://sift.jcvi.org/">http://sift.jcvi.org/</ext-link>), and Provean (<ext-link ext-link-type="uri" xlink:href="http://provean.jcvi.org/">http://provean.jcvi.org/</ext-link>) software. All three software predicted a damaging effect of the p.R141Q mutation on CYP11B1 function (<xref ref-type="table" rid="tab3">Table 3</xref>). That p.R141 is conserved in the mammalian CYP11B1 protein further suggests an important role of this residue at this position (<xref ref-type="fig" rid="fig4">Figure 4</xref>).</p>
      <p>Most of the reported mutations are private, family-specific mutations. However, in some ethnic groups, particularly in families with high rate of consanguinity, ethnic-specific<italic> CYP11B1</italic> mutations in homozygous forms have been described. These include the p.R448H mutation identified among Jewish immigrants from Morocco [<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B14" ref-type="bibr">14</xref>]. The p.Q356X (c.1066C&gt;T, rs146124466) and p.G379V (c.1136G&gt;T) mutations are associated mostly with 11<italic>Î²</italic>-OHD patients from Tunisia, although some patients with p.Q356X mutation have also been described in patients originating from Africa [<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B15" ref-type="bibr">15</xref>].</p>
      <p>Our families with 11<italic>Î²</italic>-OHD patients are all of the Croatian (Slavic) origin, and there is no self-reported consanguinity. Mutation analysis of the<italic> CYP11B1 </italic>gene revealed that the p.R448H mutation was present not only in one previously reported Croatian patient [<xref rid="B9" ref-type="bibr">9</xref>], but also in Patients 1 and 2. Thus, three patients from two Croatian families carry this mutation, which is otherwise rarely reported in Caucasians [<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B17" ref-type="bibr">17</xref>]. Also, similar to this previously reported patient, all three patients in this study carry novel<italic> CYP11B1</italic> mutations in the heterozygous form. This is consistent with former reports that most of the<italic> CYP11B1</italic> mutations are private because they can only be found within the same family [<xref rid="B13" ref-type="bibr">13</xref>].</p>
      <p>To the best of our knowledge, there are no other patients with 11<italic>Î²</italic>-OHD in the Slavic population in whom<italic> CYP11B1</italic> gene analysis has been performed. Therefore, it is imperative to perform<italic> CYP11B1</italic> genetic analysis in more patients from this region. Our investigation should benefit from genetic counseling, prenatal and postnatal diagnosis, and treatment of 11<italic>Î²</italic>-OHD in Croatia.</p>
    </sec>
  </body>
  <back>
    <sec sec-type="conflict">
      <title>Conflict of Interests</title>
      <p>All authors declare that there is no conflict of interests regarding the publication of this paper.</p>
    </sec>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nimkarn</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>New</surname>
              <given-names>MI</given-names>
            </name>
          </person-group>
          <article-title>Steroid 11<italic>Î²</italic>- hydroxylase deficiency congenital adrenal hyperplasia</article-title>
          <source>
            <italic>Trends in Endocrinology and Metabolism</italic>
          </source>
          <year>2008</year>
          <volume>19</volume>
          <issue>3</issue>
          <fpage>96</fpage>
          <lpage>99</lpage>
          <pub-id pub-id-type="other">2-s2.0-41149159338</pub-id>
          <pub-id pub-id-type="pmid">18294861</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Speiser</surname>
              <given-names>PW</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>PC</given-names>
            </name>
          </person-group>
          <article-title>Congenital adrenal hyperplasia</article-title>
          <source>
            <italic>New England Journal of Medicine</italic>
          </source>
          <year>2003</year>
          <volume>349</volume>
          <issue>8</issue>
          <fpage>776</fpage>
          <lpage>788</lpage>
          <pub-id pub-id-type="other">2-s2.0-0042466547</pub-id>
          <pub-id pub-id-type="pmid">12930931</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tonetto-Fernandes</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Lemos-Marini</surname>
              <given-names>SHV</given-names>
            </name>
            <name>
              <surname>Kuperman</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ribeiro-Neto</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Verreschi</surname>
              <given-names>ITN</given-names>
            </name>
            <name>
              <surname>Kater</surname>
              <given-names>CE</given-names>
            </name>
          </person-group>
          <article-title>Serum 21-deoxycortisol, 17-hydroxyprogesterone, and 11-deoxycortisol in classic congenital adrenal hyperplasia: clinical and hormonal correlations and identification of patients with 11<italic>Î²</italic>-hydroxylase deficiency among a large group with alleged 21-hydroxylase deficiency</article-title>
          <source>
            <italic>Journal of Clinical Endocrinology and Metabolism</italic>
          </source>
          <year>2006</year>
          <volume>91</volume>
          <issue>6</issue>
          <fpage>2179</fpage>
          <lpage>2184</lpage>
          <pub-id pub-id-type="other">2-s2.0-33744951313</pub-id>
          <pub-id pub-id-type="pmid">16551734</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Parajes</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Loidi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Reisch</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Functional consequences of seven novel mutations in the <italic><italic>CYP11B1</italic></italic> gene: four mutations associated with nonclassic and three mutations causing classic 11<italic>Î²</italic>-hydroxylase deficiency</article-title>
          <source>
            <italic>Journal of Clinical Endocrinology and Metabolism</italic>
          </source>
          <year>2010</year>
          <volume>95</volume>
          <issue>2</issue>
          <fpage>779</fpage>
          <lpage>788</lpage>
          <pub-id pub-id-type="other">2-s2.0-76149126092</pub-id>
          <pub-id pub-id-type="pmid">20089618</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peters</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Nugent</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Perry</surname>
              <given-names>LA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cosegregation of a novel homozygous <italic>CYP11B1</italic> mutation with the phenotype of non-classical congenital adrenal hyperplasia in a consanguineous family</article-title>
          <source>
            <italic>Hormone Research</italic>
          </source>
          <year>2007</year>
          <volume>67</volume>
          <issue>4</issue>
          <fpage>189</fpage>
          <lpage>193</lpage>
          <pub-id pub-id-type="other">2-s2.0-33947403636</pub-id>
          <pub-id pub-id-type="pmid">17124386</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paperna</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Gershoni-Baruch</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Badarneh</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kasinetz</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Hochberg</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title>Mutations in <italic>CYP11B1</italic> and congenital adrenal hyperplasia in Moroccan Jews</article-title>
          <source>
            <italic>Journal of Clinical Endocrinology and Metabolism</italic>
          </source>
          <year>2005</year>
          <volume>90</volume>
          <issue>9</issue>
          <fpage>5463</fpage>
          <lpage>5465</lpage>
          <pub-id pub-id-type="other">2-s2.0-24344466225</pub-id>
          <pub-id pub-id-type="pmid">16030166</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosler</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Absence of steroid biosynthetic defects in heterozygote individuals for classic 11<italic>Î²</italic>-hydroxylase deficiency due to a R448H mutation in the <italic>CYP11B1</italic> gene</article-title>
          <source>
            <italic>Journal of Clinical Endocrinology and Metabolism</italic>
          </source>
          <year>1995</year>
          <volume>80</volume>
          <issue>12</issue>
          <fpage>3771</fpage>
          <lpage>3773</lpage>
          <pub-id pub-id-type="other">2-s2.0-0028844415</pub-id>
          <pub-id pub-id-type="pmid">8530633</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>White</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Dupont</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>New</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Leiberman</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hochberg</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Rosler</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>A mutation in <italic>CYP11B1</italic> (Arg-448âHis) associated with steroid 11<italic>Î²</italic>-hydroxylase deficiency in Jews of Moroccan origin</article-title>
          <source>
            <italic>Journal of Clinical Investigation</italic>
          </source>
          <year>1991</year>
          <volume>87</volume>
          <issue>5</issue>
          <fpage>1664</fpage>
          <lpage>1667</lpage>
          <pub-id pub-id-type="other">2-s2.0-0025847381</pub-id>
          <pub-id pub-id-type="pmid">2022736</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dumic</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Thanasawat</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Steroid 11-beta hydroxylase deficiency caused by compound heterozygosity for a novel mutation in intron 7 (IVS 7 DS + 4A to G) in one <italic>CYP11B1</italic> allele and R448H in exon 8 in the other</article-title>
          <source>
            <italic>European Journal of Pediatrics</italic>
          </source>
          <year>2010</year>
          <volume>169</volume>
          <issue>7</issue>
          <fpage>891</fpage>
          <lpage>894</lpage>
          <pub-id pub-id-type="other">2-s2.0-77954423689</pub-id>
          <pub-id pub-id-type="pmid">20024693</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>DumiÄ</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>PlavsiÄ</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>BrkljaciÄ</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiencyâdifferent HLA genotypes in 2 brothers</article-title>
          <source>
            <italic>Lijecnicki Vjesnik</italic>
          </source>
          <year>1983</year>
          <volume>105</volume>
          <issue>4</issue>
          <fpage>145</fpage>
          <lpage>149</lpage>
          <pub-id pub-id-type="other">2-s2.0-0020742137</pub-id>
          <pub-id pub-id-type="pmid">6602259</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Merke</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Tajima</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Chhabra</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Novel <italic>CYP11B1</italic> mutations in congenital adrenal hyperplasia due to steroid 11<italic>Î²</italic>-hydroxylase deficiency</article-title>
          <source>
            <italic>Journal of Clinical Endocrinology and Metabolism</italic>
          </source>
          <year>1998</year>
          <volume>83</volume>
          <issue>1</issue>
          <fpage>270</fpage>
          <lpage>273</lpage>
          <pub-id pub-id-type="other">2-s2.0-0031790708</pub-id>
          <pub-id pub-id-type="pmid">9435454</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Curnow</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Slutsker</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Vitek</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutations in the <italic>CYP11B1</italic> gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8</article-title>
          <source>
            <italic>Proceedings of the National Academy of Sciences of the United States of America</italic>
          </source>
          <year>1993</year>
          <volume>90</volume>
          <issue>10</issue>
          <fpage>4552</fpage>
          <lpage>4556</lpage>
          <pub-id pub-id-type="other">2-s2.0-0027173431</pub-id>
          <pub-id pub-id-type="pmid">8506298</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bhangoo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>New</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Ten</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Donor splice mutation in the 11<italic>Î²</italic>-hydroxylase (<italic>CYP11B1</italic>) gene resulting in sex reversal: a case report and review of the literature</article-title>
          <source>
            <italic>Journal of Pediatric Endocrinology and Metabolism</italic>
          </source>
          <year>2006</year>
          <volume>19</volume>
          <issue>10</issue>
          <fpage>1267</fpage>
          <lpage>1282</lpage>
          <pub-id pub-id-type="other">2-s2.0-37849188987</pub-id>
          <pub-id pub-id-type="pmid">17172090</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Soardi</surname>
              <given-names>FC</given-names>
            </name>
            <name>
              <surname>Penachioni</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Justo</surname>
              <given-names>GZ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Novel mutations in <italic>CYP11B1</italic> gene leading to 11<italic>Î²</italic>-hydroxylase deficiency in Brazilian patients</article-title>
          <source>
            <italic>Journal of Clinical Endocrinology and Metabolism</italic>
          </source>
          <year>2009</year>
          <volume>94</volume>
          <issue>9</issue>
          <fpage>3481</fpage>
          <lpage>3485</lpage>
          <pub-id pub-id-type="other">2-s2.0-69949084546</pub-id>
          <pub-id pub-id-type="pmid">19567537</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kharrat</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Trabelsi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Chaabouni</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Only two mutations detected in 15 Tunisian patients with 11<italic>Î²</italic>-hydroxylase deficiency: the p.Q356X and the novel p.G379V</article-title>
          <source>
            <italic>Clinical Genetics</italic>
          </source>
          <year>2010</year>
          <volume>78</volume>
          <issue>4</issue>
          <fpage>398</fpage>
          <lpage>401</lpage>
          <pub-id pub-id-type="other">2-s2.0-77956396950</pub-id>
          <pub-id pub-id-type="pmid">20331679</pub-id>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Geley</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kapelari</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>JÃ¶hrer</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>
<italic>CYP11B1</italic> mutations causing congenital adrenal hyperplasia due to 11<italic>Î²</italic>-hydroxylase deficiency</article-title>
          <source>
            <italic>Journal of Clinical Endocrinology and Metabolism</italic>
          </source>
          <year>1996</year>
          <volume>81</volume>
          <issue>8</issue>
          <fpage>2896</fpage>
          <lpage>2901</lpage>
          <pub-id pub-id-type="other">2-s2.0-10144250291</pub-id>
          <pub-id pub-id-type="pmid">8768848</pub-id>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sido</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Weber</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Sido</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Clausmeyer</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Heinrich</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Schulze</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>21-Hydroxylase and 11<italic>Î²</italic>-hydroxylase mutations in Romanian patients with classic congenital adrenal hyperplasia</article-title>
          <source>
            <italic>Journal of Clinical Endocrinology and Metabolism</italic>
          </source>
          <year>2005</year>
          <volume>90</volume>
          <issue>10</issue>
          <fpage>5769</fpage>
          <lpage>5773</lpage>
          <pub-id pub-id-type="other">2-s2.0-26244453109</pub-id>
          <pub-id pub-id-type="pmid">16046588</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="fig1" orientation="portrait" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Sequencing electropherograms showing<italic> CYP11B1</italic> mutations in Patient 1. Wild-type<italic> CYP11B1</italic> DNA sequences encoding p.E67 (a) and p.R448 (c) from a normal individual are shown as reference. Patient 1 is compound heterozygous for a novel exon 1 p.E67fs (c.199delG) frameshift mutation on one allele (b) and an exon 8 p.R448H mutation on the other allele (d) of the<italic> CYP11B1</italic> gene. Patient 2, the younger brother of Patient 1, carries identical mutations.</p>
      </caption>
      <graphic xlink:href="IJE2014-185974.001"/>
    </fig>
    <fig id="fig2" orientation="portrait" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Sequencing electropherograms showing<italic> CYP11B1</italic> mutations in Patient 3. Wild-type<italic> CYP11B1</italic> DNA sequences encoding p.R141 (a) and p.T318 (c) from a normal individual are shown as reference. Patient 3 is compound heterozygous for a novel exon 3 p.R141Q mutation on one allele (b) and an exon 5 p.T318R mutation on the other allele (d) of the<italic> CYP11B1</italic> gene.</p>
      </caption>
      <graphic xlink:href="IJE2014-185974.002"/>
    </fig>
    <fig id="fig3" orientation="portrait" position="float">
      <label>Figure 3</label>
      <caption>
        <p>Schematic diagram of the human<italic> CYP11B1</italic> gene showing positions of mutations identified in this study. The two novel mutations, p.E67fs (c.199delG) in exon 1 and p.R141Q (c.422G&gt;A) in exon 3, are indicated in bold type.</p>
      </caption>
      <graphic xlink:href="IJE2014-185974.003"/>
    </fig>
    <fig id="fig4" orientation="portrait" position="float">
      <label>Figure 4</label>
      <caption>
        <p>p.R141 is conserved in mammalian<italic> CYP11B1</italic> protein. The GenBank protein sequences used for the alignment were NP_000488.3 (<italic>Homo sapiens</italic>, Human), NP_001180667.1 (<italic>Macaca mulatta</italic>, Rhesus Monkey), XP_002759236.1 (<italic>Callithrix jacchus</italic>, White-Tufted-Ear Marmoset), NP_777063.2 (<italic>Bos taurus</italic>, Cattle), NP_001068568.1 (<italic>Ovis aries</italic>, Sheep), NP_001166410.1 (<italic>Cavia porcellus</italic>, Guinea Pig), NP_001028401.2 (<italic>Mus musculus</italic>, Mouse), and NP_036669.3 (<italic>Rattus norvegicus</italic>, Rat). p.R141 is in bold letter. Fully (asterisk), strongly (colon), and weakly (period) conserved residues are indicated.</p>
      </caption>
      <graphic xlink:href="IJE2014-185974.004"/>
    </fig>
    <table-wrap id="tab1" orientation="portrait" position="float">
      <label>Table 1</label>
      <caption>
        <p>Hormonal analyses of Patient 3.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left" rowspan="1" colspan="1">Hormones</th>
            <th align="center" rowspan="1" colspan="1">Results</th>
            <th align="center" rowspan="1" colspan="1">Normal range</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left" rowspan="1" colspan="1">11-deoxycortisol (nmol/L)</td>
            <td align="center" rowspan="1" colspan="1">186</td>
            <td align="center" rowspan="1" colspan="1">0.1â2.0</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">17-hydroxyprogesterone (nmol/L)</td>
            <td align="center" rowspan="1" colspan="1">36</td>
            <td align="center" rowspan="1" colspan="1">1.5â7.0</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">Androstenedione (nmol/L)</td>
            <td align="center" rowspan="1" colspan="1">5</td>
            <td align="center" rowspan="1" colspan="1">0.3â1.5</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">Testosterone (nmol/L)</td>
            <td align="center" rowspan="1" colspan="1">2.2</td>
            <td align="center" rowspan="1" colspan="1">0.1â0.3</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">Cortisol (nmol/L)</td>
            <td align="center" rowspan="1" colspan="1">102</td>
            <td align="center" rowspan="1" colspan="1">140â690</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">Aldosterone (pmol/L)</td>
            <td align="center" rowspan="1" colspan="1">160</td>
            <td align="center" rowspan="1" colspan="1">200â800</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">PRA (<italic>Î¼</italic>gL<sup>â1</sup>h<sup>â1</sup>)</td>
            <td align="center" rowspan="1" colspan="1">1.1</td>
            <td align="center" rowspan="1" colspan="1">2.0â5.2</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
    <table-wrap id="tab2" orientation="portrait" position="float">
      <label>Table 2</label>
      <caption>
        <p>List of primers for PCR amplification and DNA sequencing of the <italic>CYP11B1</italic> gene.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left" rowspan="1" colspan="1">Primer sequence</th>
            <th align="center" rowspan="1" colspan="1">Location</th>
            <th align="center" rowspan="1" colspan="1">Orientation</th>
            <th align="center" rowspan="1" colspan="1">Purpose</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left" rowspan="1" colspan="1">TCGAAGGCAAGGCACCAG</td>
            <td align="center" rowspan="1" colspan="1">Promoter</td>
            <td align="center" rowspan="1" colspan="1">sense</td>
            <td align="center" rowspan="1" colspan="1">Exons 1-2 amplification</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">TGCTCCCAGCTCTCAGCT</td>
            <td align="center" rowspan="1" colspan="1">Intron 2</td>
            <td align="center" rowspan="1" colspan="1">antisense</td>
            <td align="center" rowspan="1" colspan="1">Exons 1-2 amplification and Exon 1 sequencing</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">AGAAAATCCCTCCCCCCTA</td>
            <td align="center" rowspan="1" colspan="1">Intron 2</td>
            <td align="center" rowspan="1" colspan="1">sense</td>
            <td align="center" rowspan="1" colspan="1">Exons 3â5 amplification</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">GACACGTGGGCGCCGTGTGA</td>
            <td align="center" rowspan="1" colspan="1">Intron 5</td>
            <td align="center" rowspan="1" colspan="1">antisense</td>
            <td align="center" rowspan="1" colspan="1">Exons 3â5 amplification</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">TGACCCTGCAGCTGTGTCT</td>
            <td align="center" rowspan="1" colspan="1">Intron 5</td>
            <td align="center" rowspan="1" colspan="1">sense</td>
            <td align="center" rowspan="1" colspan="1">Exons 6â9 amplification</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">GAGACGTGATTAGTTGATGGC</td>
            <td align="center" rowspan="1" colspan="1">Exon 9, 3â² UTR</td>
            <td align="center" rowspan="1" colspan="1">antisense</td>
            <td align="center" rowspan="1" colspan="1">Exons 6â9 amplification</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">CACCAGGCAAGATAAAAG</td>
            <td align="center" rowspan="1" colspan="1">Promoter</td>
            <td align="center" rowspan="1" colspan="1">sense</td>
            <td align="center" rowspan="1" colspan="1">Exon 1 sequencing</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">AGACACTTTGGATTGGGAC</td>
            <td align="center" rowspan="1" colspan="1">Intron 1</td>
            <td align="center" rowspan="1" colspan="1">sense</td>
            <td align="center" rowspan="1" colspan="1">Exon 2 sequencing</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">AGGATGCACTGCTGAGCAC</td>
            <td align="center" rowspan="1" colspan="1">Intron 3</td>
            <td align="center" rowspan="1" colspan="1">antisense</td>
            <td align="center" rowspan="1" colspan="1">Exon 3 sequencing</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">GTGGAGAGGGAGAAATTGGG</td>
            <td align="center" rowspan="1" colspan="1">Intron 4</td>
            <td align="center" rowspan="1" colspan="1">antisense</td>
            <td align="center" rowspan="1" colspan="1">Exon 4 sequencing</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">AGGATGTTTCCCAGCACCAAAG</td>
            <td align="center" rowspan="1" colspan="1">Intron 4</td>
            <td align="center" rowspan="1" colspan="1">sense</td>
            <td align="center" rowspan="1" colspan="1">Exon 5 sequencing</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">ATTCCAGAGGAAGAAGAGC</td>
            <td align="center" rowspan="1" colspan="1">Intron 6</td>
            <td align="center" rowspan="1" colspan="1">antisense</td>
            <td align="center" rowspan="1" colspan="1">Exon 6 sequencing</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">CATGGATCTGGGACCTCTG</td>
            <td align="center" rowspan="1" colspan="1">Intron 6</td>
            <td align="center" rowspan="1" colspan="1">sense</td>
            <td align="center" rowspan="1" colspan="1">Exon 7 sequencing</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">AGGCCAGTCCCACATTGCTC</td>
            <td align="center" rowspan="1" colspan="1">Intron 8</td>
            <td align="center" rowspan="1" colspan="1">antisense</td>
            <td align="center" rowspan="1" colspan="1">Exon 8 sequencing</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">CCCCCTTCAGCATAATCTC</td>
            <td align="center" rowspan="1" colspan="1">Intron 8</td>
            <td align="center" rowspan="1" colspan="1">sense</td>
            <td align="center" rowspan="1" colspan="1">Exon 9 sequencing</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn>
          <p>
(Footnote) 3â² UTR: 3â² untranslated region.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="tab3" orientation="portrait" position="float">
      <label>Table 3</label>
      <caption>
        <p>
<italic>In silico</italic> prediction of the effects of the p.R141Q mutation in <italic>CYP11B1</italic> function.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left" rowspan="1" colspan="1">Prediction software</th>
            <th align="center" rowspan="1" colspan="1">Score</th>
            <th align="center" rowspan="1" colspan="1">Prediction of Effects of Mutation</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left" rowspan="1" colspan="1">PolyPhen-2 (<ext-link ext-link-type="uri" xlink:href="http://genetics.bwh.harvard.edu/pph2/">http://genetics.bwh.harvard.edu/pph2</ext-link>)</td>
            <td align="center" rowspan="1" colspan="1">1.000</td>
            <td align="center" rowspan="1" colspan="1">Probably Damaging</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">SIFT (<ext-link ext-link-type="uri" xlink:href="http://sift.jcvi.org/">http://sift.jcvi.org</ext-link>)</td>
            <td align="center" rowspan="1" colspan="1">0.000</td>
            <td align="center" rowspan="1" colspan="1">Damaging</td>
          </tr>
          <tr>
            <td align="left" rowspan="1" colspan="1">Provean (<ext-link ext-link-type="uri" xlink:href="http://provean.jcvi.org/index.php">http://provean.jcvi.org</ext-link>)</td>
            <td align="center" rowspan="1" colspan="1">â3.769</td>
            <td align="center" rowspan="1" colspan="1">Deleterious</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
  </floats-group>
</article>

</metadata></record></GetRecord></OAI-PMH>